| Literature DB >> 33884132 |
Rudi Frankinouille1, Greetje Vanhoutte2, Gaëtane Stassijns3, Carmen De Coster2, Ella Roelant4, Marika Rasschaert1, Jan Gielen5, Sevilay Altintas6, Marc Peeters2,6.
Abstract
OBJECTIVE: It is recommended that cancer survivors incorporate physical activity into their daily lives after in-hospital rehabilitation. However, there is a lack of training programmes focusing on the specific needs of cancer survivors. TriaGO! - an 8-month intervention study of aerobic endurance training for cancer survivors - was therefore examined. The training programme aims to meet the participants' physical needs and provide socio-emotional support, in the form of an exercise programme that challenges participants to aim to compete in an Olympic- distance triathlon (1,000 m swimming, 45 km cycling, 10 km running) after 8 months' of training.Entities:
Keywords: cancer survivors; oncology; supervised training; triathlon
Year: 2020 PMID: 33884132 PMCID: PMC8008719 DOI: 10.2340/20030711-1000030
Source DB: PubMed Journal: J Rehabil Med Clin Commun ISSN: 2003-0711
Fig. 1Physical evaluation and test results at inclusion, baseline evaluation and intermediate physical evaluation. Inclusion variables used to measure: body composition (orange), aerobic fitness (blue) and muscular fitness (green). CPET: cardiopulmonary exercise testing; VASO: VASO: Vlaamse Aanbeveling Sportmedisch Onderzoek; BMI: body mass index; ECG: electrocardiography; VO2peak: peak oxygen uptake; VO2max: maximum oxygen uptake.
Fig. 3CONSORT (Consolidated Standards of Reporting Trials) flow diagram of progress through the phases of participant inclusion and screening. CPET: cardiopulmonary exercise testing; VASO: Vlaamse Aanbeveling Sportmedisch Onderzoek.
Participants' characteristics (n = 12)
| Cancer survivors | Buddies | |
|---|---|---|
| Cancer history, | ||
| Breast | 9 | |
| Colorectal | 2 | |
| Carcinoid | 1 | |
| Cancer treatment | ||
| Surgery | 1 | |
| Surgery/chemotherapy | 3 | |
| Surgery/chemotherapy/radiation | 8 | |
| Median time post treatment, years | 2.1 | |
| SR-score, n | ||
| Weak | 1 | 1 |
| Very moderate | 1 | 2 |
| Moderate | 3 | 2 |
| Average | 3 | 2 |
| Good | 2 | 2 |
| Very good | 1 | 2 |
| Excellent | 1 | 1 |
| Median age, years | 47 | 40.5 |
| Kuipers' index, | ||
| Weak | 4 | 3 |
| Very moderate | 6 | 3 |
| Moderate | 1 | 5 |
| Average | 1 | 1 |
| Good | 0 | 0 |
| Very good | 0 | 0 |
| Excellent | 0 | 0 |
| Sex, male/female, n | 3/9 | 4/8 |
Cancer-related characteristics of cancer survivors (cancer history, treatment and post-treatment median time at start of training), and performance parameters (SR-score and Kuipers' index) at baseline for all participants, both cancer survivors and buddies
Physical evaluation. Measured outcomes (mean (SD) at 3 time-points (baseline, 4 months, and 8 months) for both cancer survivors and buddies.
| Baseline | 4 months | 8 months | Global improvement baseline vs endpoint | Adjusted | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Physical evaluation | Cancer survivors Mean (SD) | Buddies Mean (SD) | Cancer survivors Mean (SD) | Buddies Mean (SD) | Cancer survivors Mean (SD) | Buddies Mean (SD) | Cancer survivors, % | Buddies, % | 0 vs 8 m | 0 vs 4 m | 4 vs 8 m | |
| Body composition | ||||||||||||
| BMI, kg/m2 | 25.49 (4.06) | 24.96 (4.78) | 25.09 (3.52) | 24.17 (4.14) | 24.53 (3.22) | 24.28 (4.01) | 0.97 | 0.46 | 0.3229 | 0.1382 | ||
| Waist circumference, cm | 89.75 (11.9) | 89.17 (11.42) | 86.14 (8.56) | 80.56 (7.81) | 82.21 (8.96) | 79.45 (6.12) | 7.54 | 6.05 | 0.3965 | |||
| Fat mass, % | 33.42 (5.12) | 29.82 (6.53) | 30.84 (5.14) | 27.39 (8.46) | 31.29 (4.54) | 27.76 (7.13) | 2.13 | 1.52 | 0.667 | |||
| Aerobic fitness | ||||||||||||
| VO2max, ml/kg/min 31.53 (7) | 35.92 (8.28) | 34.55 (5.66) | 40.22 (8.08) | 37.45 (5.44) | 42.36 (9.79) | 5.93 | 5.39 | |||||
| VO2peak, ml/min | 2.31 (0.62) | 2.62 (0.64) | 2.47 (0.53) | 2.75 (0.54) | 2.64 (0.65) | 2.85 (0.57) | 0.33 | 0.18 | 0.3572 | |||
| SR-score | 3.91 (1.76) | 4 (1.86) | 4.6 (1.43) | 4.9 (1.6) | 5.09 (1.45) | 5.25 (2.05) | 1.18 | 1.38 | ||||
| Muscular fitness | ||||||||||||
| Wmax, W | 154.8 (46.72) 171.3 (51.77) | 164 (40.55) | 186.6 (43.68) | 182.7 (47.17) 203.3 (54.25) | 27.92 | 29.12 | ||||||
| W/kg | 2.21 (0.57) | 2.45 (0.71) | 2.45 (0.53) | 2.72 (0.61) | 2.67 (0.46) | 2.88 (0.76) | 0.47 | 0.34 | ||||
| Kuipers’ index | 1.92 (0.9) | 2.33 (0.98) | 2.27 (0.9) | 2.7 (0.95) | 2.58 (0.67) | 3 (1.51) | 0.67 | 0.50 | 0.1371 | |||
| Max speed, km/h | 11.02 (1.53) | 11.7 (1.95) | 12.11 (1.25) | 12.71 (2.11) | 12.65 (1.44) | 13.38 (1.87) | 1.42 | 1.41 | ||||
Mean differences between baseline and endpoint values are shown in the “Global improvement” column for both groups. Improvements in body composition-related outcomes are procentual decreases, improvements for aerobic fitness and muscular fitness are procentual increases. The right-hand column shows adjusted p-values resulting from 2×2 comparisons of the different time-points for all participants together. (Bold font if significant). m: months; SD: standard deviation; BMI: body mass index; VO2peak: peak oxygen uptake; VO2max: maximum oxygen uptake; SR-score: Shvartz-Reibold score.
Fig. 4Change in outcomes in cancer survivors and buddies over time, by category: (A) body composition, (B) aerobic fitness, and (C) muscular fitness, during the intermediate physical tests, showing ratios compared to baseline expressed as percentage. m: months; BMI: body mass index; VO2peak: peak oxygen uptake; VO2max: maximum oxygen uptake; SR-score: Shvartz-Reibold score. Solid lines: cancer survivors; dashed lines: buddies.